The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers.

The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers. Abstract Text:

H Gregersen,S Rittig,K Kraglund,S Phillips,

Since it has been argued that the spasmolytic effect of glucagon is related to the first 21 N-terminal amino acid residues, and not to the complete molecule, we have compared the effects of glucagon-(1-21)-peptide (G-(1-21) and glucagon on human antroduodenal motility. Glucagon and G-(1-21) were given as bolus injections to 30 healthy volunteers equally allocated into five groups. Each subject received two doses; one was placebo, 0.25, 0.5, 1.0 or 2.0 mg of glucagon, the other was an equimolar doses of G-(1-21) (placebo, 0.175, 0.35, 0.70 or 1.4 mg of G-1-21). The first injection was given during phase II of a migrating motility complex (MMC), and the next during the following phase II. Contractile activity was recorded using an oral tube with one sidehole positioned in the antrum and two in the duodenum. We confirmed that glucagon decreases the number of contractions in the antrum and duodenum and that normal phase II activity was restored within 20-40 minutes proportionally to the amount of the drug given. G-(1-21) did not change antroduodenal motility nor did it affect the phase II pattern in any of the groups. Neither were any side effects encountered. G-(1-21) does not seem to be an alternative to glucagon and other spasmolytic drugs for obtaining relaxation of the antroduodenal area.

The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers. Publishing Authors By Initials

H Gregersen,S Rittig,K Kraglund,S Phillips,

For similar peptides: peptide fragments research abstracts see: peptides: peptide fragments research

PUBMED ID PMID:

MEDLINE DATE:

The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Scandinavian journal of gastroenterology. Suppleme

VOLUME: 152

Page Numbers: 42-7

Journal Abbreviation: Scand. J. Gastroenterol. Suppl

ISSN: 0085-5928

DAY: 13

MONTH: 02

YEAR: 1988

The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 437034

The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers. Keywords Mesh Terms:

KEYWORDS: Peptide Fragments

MESH TERMS: pharmacology

Chemical & Substance for Abstract: The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers. Information

Substance Name: Glucagon

Registry Number: 9007-92-5

Grant and Affiliation Information for The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers.

AFFILIATION: Department of Surgical Gastroenterology, Aarhus Municipal Hospital, University of Aarhus, Denmark.

Country: NORWAY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Scand J Gastroenterol Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The effects of glucagon and glucagon-1-21-peptide on antroduodenal motility in healthy volunteers Related Publications

• Carrageenan/MIV-150 (PC-815), a combination microbicide.
• Curvilinear associations between benefit finding and psychosocial adjustment to breast cancer.
• Determinants of the variability of aflatoxin-albumin adduct levels in Ghanaians.
• Drifting blooms of the endemic filamentous brown alga Hincksia sordida at Noosa on the subtropical east Australian coast.
• Ethanol-related traits in mice selectively bred for differential sensitivity to methamphetamine-induced activation.
• GABAB receptor stimulation accentuates the locomotor effects of morphine in mice bred for extreme sensitivity to the stimulant effects of ethanol.
• Gravity: It's the law.
• Is 'alcoholism' genetically transmitted? And are there any implications for prevention?
• Optimization and evaluation of a coarse-grained model of protein motion using x-ray crystal data.
• Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost?
• Pathological skin picking in individuals with body dysmorphic disorder.
• Postchallenge glucose rises with increasing age even when glucose tolerance is normal.
• Relaxed selection among duplicate floral regulatory genes in Lamiales.
• Response of interleukin-1beta in the magnocellular system to salt-loading.
• Sensitivity to the locomotor-stimulant effects of ethanol and allopregnanolone: a quantitative trait locus study of common genetic influence.
• Social functioning in body dysmorphic disorder: assessment considerations.
• Structure and dynamics of UDP-glucose pyrophosphorylase from Arabidopsis thaliana with bound UDP-glucose and UTP.
• Structure of aspartoacylase, the brain enzyme impaired in Canavan disease.
• The limits of reductionism in medicine: could systems biology offer an alternative?
• The opportunity for canalization and the evolution of genetic networks.
• The role of structural prediction in rapid syntactic analysis.
• The time resolved fluorescence and anisotropy of subtilisins BPN' and Carlsberg.
• Total synthesis of (-)-dictyostatin.
• Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes.
• Two- or four-hour lying deprivation on the behavior of lactating dairy cows.
• UPJ Obstruction in the Adult Population: Are Crossing Vessels Significant?
• Variation in pleiotropy and the mutational underpinnings of the G-matrix.
• Weight concerns in individuals with body dysmorphic disorder.
• X-ray crystal structures of the conserved hypothetical proteins from Arabidopsis thaliana gene loci At5g11950 and AT2g37210.
• [Survey of suicidal ideation and suicide attempts in outpatients at 50 general hospitals in Beijing]